CD36-Expressing Dermal Sheath Cells for Hair Follicle Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for hair follicle regeneration lack understanding of the mechanisms involving dermal sheath cells (DSc) and their role in hair follicle formation, limiting effective hair growth promotion and follicle reconstruction.
Innovation Solution
A composition comprising CD36-expressing dermal sheath cells and dermal papilla cells, with a specific ratio, derived from mice, rats, or humans, is used for hair follicle regeneration through transplantation or in a three-dimensional skin model, leveraging the promotional effects of CD36 and HGF on hair growth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If dermal sheath cells are used for hair follicle regeneration, then hair growth promotion is improved, but the mechanism understanding is insufficient
Solution Approach 1:
The patent employs microarray analysis to profile gene expression in dermal sheath cells, creating a feedback loop that identifies CD36 as a key marker. This molecular feedback mechanism transforms the black box of hair follicle regeneration into a controllable process by establishing CD36 expression levels as a measurable indicator of cell identity and function, thereby resolving the information gap while maintaining productivity.
Solution Approach 2:
The patent uses immunohistochemical staining with CD36-specific antibodies to visually identify and characterize dermal sheath cells. This staining technique provides a visual marker (color change) that allows researchers to distinguish CD36-positive dermal sheath cells from other cell types, transforming the invisible molecular mechanism into observable data that enhances understanding while preserving the hair growth promotion capability.
2Reliability
If CD36-expressing dermal sheath cells are isolated and transplanted, then hair follicle regeneration is enhanced, but cell isolation complexity increases
Solution Approach 1:
The patent changes the identification parameter from general morphological characteristics to specific molecular markers (CD36 expression). By establishing CD36 as a defining parameter for dermal sheath cells, the patent enables more reliable cell isolation and characterization, enhancing regeneration reliability while providing a clear, measurable criterion that simplifies the isolation process through targeted selection.
3Reliability
If dermal papilla cells and dermal sheath cells are combined, then follicle reconstruction is improved, but composition complexity increases
Solution Approach 1:
The patent segments the hair follicle reconstruction process into distinct cellular components with defined roles: dermal papilla cells (identified by specific markers) and dermal sheath cells (identified by CD36 expression). This segmentation allows each cell type to be isolated, characterized, and transplanted separately, improving reconstruction reliability through optimized cell ratios and functions while managing composition complexity through systematic organization of cell components.
Data Source
AI summary
Provided is a method for regenerating hair follicles by transplanting a composition containing CD36-expressing dermal sheath cells (DSc) to a human. The composition may be prepared by sorting CD36-expressing dermal sheath cells from a hair follicle tissue by use of a cell-sorting technique along with an antibody to CD36. The composition may also contain dermal papilla cells (DPc).